DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Performance 10 years - DRIO ranking 42 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.49K
3. Medpace Holdings MEDP
1.24K
4. RadNet RDNT
964.23
5. DexCom DXCM
671.61
6. IDEXX Laboratories IDXX
648.67
7. Icon ICLR
520.63
8. Mettler-Toledo MTD
461.76
9. Danaher DHR
461.25
10. Natera NTRA
453.44
11. Thermo Fisher Scientific TMO
407.07
12. IQVIA Holdings IQV
337.77
13. Charles River Laboratories CRL
335.9
14. Exact Sciences EXAS
265.99
15. PerkinElmer PKI
247.07
16. Agilent Technologies A
245.93
17. Waters WAT
235.07
18. Twist Bioscience TWST
230.54
19. NeoGenomics NEO
225.19
20. Fulgent Genetics FLGT
172.1
21. Laboratory Corp of America Holdings LH
166.16
22. CareDx CDNA
146.55
23. Quest Diagnostics DGX
146.52
24. Syneos Health SYNH
113.83
25. National Research NRC
88.81
26. Qiagen QGEN
83.25
27. Meridian Bioscience VIVO
60.69
28. Guardant Health GH
14.41
29. Ortho Clinical Diagnostics Holdings OCDX
13.74
30. Neogen NEOG
1.16
31. Inotiv NOTV
-25.11
32. Olink Holding OLK
-26.82
33. Illumina ILMN
-26.84
34. Myriad Genetics MYGN
-28.46
35. Sera Prognostics SERA
-45.9
36. Anixa Biosciences ANIX
-47.2
37. Sotera Health SHC
-51.04
38. Bioventus BVS
-55.96
39. Pacific Biosciences of California PACB
-62.64
40. Global Cord Blood CO
-66.57
41. MaxCyte MXCT
-74.28
42. DarioHealth DRIO
-75.47
43. Enzo Biochem ENZ
-75.66
44. MDxHealth MDXH
-78.6
45. bioAffinity Technologies BIAF
-79.4
46. Co-Diagnostics CODX
-81.83
47. Personalis PSNL
-84.75
48. Psychemedics PMD
-85.68
49. Exagen XGN
-87.86
50. Biodesix BDSX
-88.08
51. Trinity Biotech TRIB
-88.17
52. Neuronetics STIM
-92.8
53. SeqLL SQL
-95.22
54. Prenetics Global PRE
-95.49
55. Aspira Womens Health AWH
-97.44
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.63
58. Precipio PRPO
-99.81

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.